1. Design, synthesis and optimization of 7-substituted-pyrazolo[4, 3-b]pyridine ALK5 (activin receptor-like kinase 5) inhibitors. Issue 9 (1st May 2017) Authors: Sabat, Mark; Wang, Haixia; Scorah, Nick; Lawson, J. David; Atienza, Joy; Kamran, Ruhi; Hixon, Mark S.; Dougan, Douglas R. Journal: Bioorganic & medicinal chemistry letters Issue: Volume 27:Issue 9(2017) Page Start: 1955 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Design, synthesis and optimization of novel Alk5 (activin-like kinase 5) inhibitors. Issue 17 (1st September 2016) Authors: Wang, Haixia; Lawson, J. David; Scorah, Nick; Kamran, Ruhi; Hixon, Mark S.; Atienza, Joy; Dougan, Douglas R.; Sabat, Mark Journal: Bioorganic & medicinal chemistry letters Issue: Volume 26:Issue 17(2016) Page Start: 4334 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Rational discovery of a highly novel and selective mTOR inhibitor. Issue 21 (1st November 2019) Authors: Jin, Stanley; Mikami, Satoshi; Scorah, Nick; Chen, Young; Halkowycz, Petro; Shi, Lihong; Kahana, Jason; Vincent, Patrick; de Jong, Ron; Atienza, Joy; Fabrey, Robyn; Zhang, Lilly; Lardy, Matthew Journal: Bioorganic & medicinal chemistry letters Issue: Volume 29:Issue 21(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗